Journey Medical Corporation Annual report pursuant to Section 13 and 15(d)

INTEREST EXPENSE AND FINANCING FEES

12 Months Ended

Dec. 31, 2022

NOTE 13. INTEREST EXPENSE AND FINANCING FEES

Interest expense and financing fees for the years ended December 31, 2022 and 2021 consisted of the following:


	Year Ended December 31,
	2022		2021
Interest payments on EWB term loan and LOC	$	1,153	$	—
Imputed Interest on acquired intangible assets		519		781
Amortization/Accretion		347		2,572
Interest and Fees on convertible preferred shares		—		2,845
Dividends payable on convertible preferred shares		—		820
EWB LOC Fees		—		16
Total Interest Expense and Financing Fees	$	2,019	$	7,034